Company profile: 3D Bio-Tissues
1.1 - Company Overview
Company description
- Provider of bio-equivalent tissues for clinical and cellular agriculture, including 3DBT corneas engineered to match human donor corneas, Tissue Templating Technology for structured, scalable tissues without animal components, City-Mix culture media supplement to enhance cell performance, and Etsyl, a lipopeptide that stimulates collagen production for cosmetic and pharmacological use.
Products and services
- Animal-free Tissue Templating Technology: engineers structured, functional, scalable tissues via a process suitable for clinical and cellular agriculture applications without animal components
- Bio-equivalent 3DBT Corneas: developed to match human donor corneas in structure and function, using human cells without artificial materials to recreate donor-like performance
- Non-toxic City-Mix: a culture media supplement designed to enhance culture performance by mimicking natural cellular environments for better results
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to 3D Bio-Tissues
Complete Genomics
HQ: United States
Website
- Description: Provider of DNA sequencing platforms for human genome sequencing and analysis, supporting commercial-scale research into genetic mechanisms underlying drug responses and complex diseases. Offerings include DNBSEQ-T7 and DNBSEQ-T20x2 ultra-high throughput sequencers, DNBSEQ-G400 high throughput, DNBSEQ-G99 fast mid throughput, DNBSEQ-E25 portable, and CoolMPS for genomic analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Complete Genomics company profile →
Primerdesign
HQ: United Kingdom
Website
- Description: Provider of real-time PCR solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Primerdesign company profile →
Tagarno
HQ: Denmark
Website
- Description: Provider of digital microscopes with 60 FPS, auto focus, and ergonomic design for specialists in materials science, agriculture, food, electronics, and forensics. Portfolio includes TREND for quality control with apps and accessories, FRONT for high-power inspections, MOVE and ZAP flexarm models, and ZIP for simple magnification and high-quality image capture.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tagarno company profile →
Surmodics
HQ: United States
Website
- Description: Provider of surface modification and in vitro diagnostic technologies to the healthcare industry, and developer and commercializer of highly differentiated vascular intervention medical devices designed to address unmet clinical needs and engineered to the most demanding requirements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Surmodics company profile →
Peloton Therapeutics
HQ: United States
Website
- Description: Provider of cancer drug discovery and development based in Dallas. Offers a clinical-stage small-molecule HIF-2α inhibitor targeting hypoxia-inducible factor-2α for kidney cancer and other disorders, and research programs to discover compounds that modulate disease-driving protein-protein interactions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Peloton Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for 3D Bio-Tissues
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to 3D Bio-Tissues
2.2 - Growth funds investing in similar companies to 3D Bio-Tissues
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for 3D Bio-Tissues
4.2 - Public trading comparable groups for 3D Bio-Tissues
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →